These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8755579)

  • 1. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
    Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.
    Li Y; Hao Y; Owyang C
    J Clin Invest; 2000 Feb; 105(3):351-9. PubMed ID: 10675361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion.
    Lu L; Louie D; Owyang C
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G430-5. PubMed ID: 2465698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide.
    Herzig KH; Louie DS; Owyang C
    Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the action of the novel cholecystokinin-releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate.
    Herzig KH; Wilgus C; Schön I; Tatemoto K; Fölsch UR
    Regul Pept; 1998 Jun; 74(2-3):193-8. PubMed ID: 9712181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion.
    Spannagel AW; Green GM; Guan D; Liddle RA; Faull K; Reeve JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4415-20. PubMed ID: 8633081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide.
    Miyasaka K; Guan DF; Liddle RA; Green GM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G175-81. PubMed ID: 2764106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-releasing activity of rat intestinal secretion: effect of atropine and comparison with monitor peptide.
    Guan D; Ohta H; Tawil T; Liddle RA; Green GM
    Pancreas; 1990 Nov; 5(6):677-84. PubMed ID: 2281081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a cholecystokinin-releasing peptide: biochemical characterization and physiological implications.
    Owyang C
    Chin J Physiol; 1999 Sep; 42(3):113-20. PubMed ID: 10707884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin- and secretin-releasing peptides in the intestine--a new regulatory interendocrine mechanism in the gastrointestinal tract.
    Herzig KH
    Regul Pept; 1998 Feb; 73(2):89-94. PubMed ID: 9533812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative feedback control of exocrine pancreatic secretion: role of cholecystokinin and cholinergic pathway.
    Owyang C
    J Nutr; 1994 Aug; 124(8 Suppl):1321S-1326S. PubMed ID: 7914921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of taurocholate on CCK release and pancreatic secretion produced by two CCK-releasing peptides in conscious rats.
    Miyasaka K; Funakoshi A; Shikado F; Uda K; Kitani K
    Pancreas; 1992; 7(5):536-42. PubMed ID: 1513801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells.
    Bouras EP; Misukonis MA; Liddle RA
    Am J Physiol; 1992 May; 262(5 Pt 1):G791-6. PubMed ID: 1590389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor (LCRF).
    Spannagel AW; Reeve JR; Greeley GH; Yanaihara N; Liddle RA; Green GM
    Regul Pept; 1998 Feb; 73(3):161-4. PubMed ID: 9556078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cholecystokinin secretion by intraluminal releasing factors.
    Liddle RA
    Am J Physiol; 1995 Sep; 269(3 Pt 1):G319-27. PubMed ID: 7573441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice.
    Miyasaka K; Funakoshi A; Matsumoto M; Kitani K
    Dig Dis Sci; 1993 Apr; 38(4):674-9. PubMed ID: 8462366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors.
    Miyasaka K; Funakoshi A
    Pancreas; 1998 Apr; 16(3):277-83. PubMed ID: 9548667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats.
    Li Y; Hao Y; Owyang C
    Gastroenterology; 1995 Jul; 109(1):231-8. PubMed ID: 7797020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.